At OHSU’s Knight Cancer Institute, Dr. Brian Druker is optimistic about harnessing advances in tech to analyze data about cancers, leading to better outcomes.
PORTLAND, Ore. — At OHSU’s Knight Cancer Institute, researchers are focused on finding ways to detect cancer earlier and produce more targeted treatments for individual types of cancer. But with so much variety in cancers, let alone the human body, the amounts of data they need to gather and analyze is mind-bogglingly vast.
That’s where advancements in tech like artificial intelligence are coming in clutch — helping researchers not only compile all that data, but potentially to go through it all and find patterns that researchers can use to help cancer patients.
Dr. Brian Druker is one such cancer researcher. He’s also CEO of the Knight Cancer Institute, funded through a billion-dollar endowment sourced from Phil and Penny Knight, taxpayers and thousands of people who donated …